|
1
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J, Yang R, Dong Y, Chen M, Wang Y and
Wang G: Knockdown of FOXO3a induces epithelial-mesenchymal
transition and promotes metastasis of pancreatic ductal
adenocarcinoma by activation of the β-catenin/TCF4 pathway through
SPRY2. J Exp Clin Cancer Res. 38:382019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hou X, Yang L, Jiang X, Liu Z, Li X, Xie
S, Li G and Liu J: Role of microRNA-141-3p in the progression and
metastasis of hepatocellular carcinoma cell. Int J Biol Macromol.
128:331–339. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamaguchi H, Wyckoff J and Condeelis J:
Cell migration in tumors. CurrOpin Cell Biol. 17:559–564. 2005.
|
|
7
|
Wan L, Pantel K and Kang Y: Tumor
metastasis: Moving new biological insights into the clinic. Nat
Med. 19:1450–1464. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Serrano-Gomez SJ, Maziveyi M and Alahari
SK: Regulation of epithelial-mesenchymal transition through
epigenetic and post-translational modifications. Mol Cancer.
15:182016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Yue B, Yu X, Wang Z and Wang M:
SLUG is activated by nuclear factor kappa B and confers human
alveolar epithelial A549 cells resistance to tumor necrosis
factor-alpha-induced apoptosis. World J Surg Oncol. 11:122013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uchikado Y, Natsugoe S, Okumura H,
Setoyama T, Matsumoto M, Ishigami S and Aikou T: Slug expression in
the E-cadherin preserved tumors is related to prognosis in patients
with esophageal squamous cell carcinoma. Clin Cancer Res.
11:1174–1180. 2005.PubMed/NCBI
|
|
11
|
Nusse R: Wnt signaling in disease and in
development. Cell Res. 15:28–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rao TP and Kühl M: An updated overview on
Wnt signaling pathways: A prelude for more. Circ Res.
106:1798–1806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial- mesenchymaltransition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jang GB, Kim JY, Cho SD, Park KS, Jung JY,
Lee HY, Hong IS and Nam JS: Blockade of Wnt/β-catenin signaling
suppresses breast cancer metastasis by inhibiting CSC-like
phenotype. Sci Rep. 5:124652015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boyer B, Tucker GC, Vallés AM, Franke WW
and Thiery JP: Rearrangements of desmosomal and cytoskeletal
proteins during the transition from epithelial to fibroblastoid
organization in cultured rat bladder carcinoma cells. J Cell Biol.
109:1495–1509. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang Y, He W, Tulley S, Gupta GP,
Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and
Massagué J: Breast cancer bone metastasis mediated by the smad
tumor suppressor pathway. Proc Natl Acad Sci USA. 102:13909–13914.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Loll PJ, Picot D and Garavito RM: The
structural basis of aspirin activity inferred from the crystal
structure of inactivated prostaglandin H2 synthase. Nat Struct
Biol. 2:637–643. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Funk CD, Funk LB, Kennedy ME, Pong AS and
Fitzgerald GA: Human platelet/erythroleukemia cell prostaglandin
G/H synthase: CDNA cloning, expression, and gene chromosomal
assignment. FASEB J. 5:2304–2312. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ying J, Zhou HY, Liu P, You Q, Kuang F,
Shen YN and Hu ZQ: Aspirin inhibited the metastasis of colon cancer
cells by inhibiting the expression of toll-like receptor 4. Cell
Biosci. 8:12018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Yuan X, Li W, Cao Q and Shu Y:
Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through
the inhibition of the mTOR pathway by reducing the expression of
PKM2 and is closely linked to oxidative stress. Int J Mol Med.
38:1235–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meyer-Schaller N, Heck C, Tiede S, Yilmaz
M and Christofori G: Foxf2 plays a dual role during transforming
growth factor beta-induced epithelial to mesenchymal transition by
promoting apoptosis yet enabling cell junction dissolution and
migration. Breast Cancer Res. 20:1182018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dihlmann S, Klein S and Doeberitz Mv Mv:
Reduction of beta-catenin/T-Cell transcription factor signaling by
aspirin and indomethacin is caused by an increased stabilization of
phosphorylated beta-catenin. Mol Cancer Ther. 2:509–516.
2003.PubMed/NCBI
|
|
25
|
Bos CL, Kodach LL, van den Brink GR, Diks
SH, van Santen MM, Richel DJ, Peppelenbosch MP and Hardwick J:
Effect of aspirin on the Wnt/beta-catenin pathway is mediated via
protein phosphatase 2A. Oncogene. 25:6447–6456. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khan P, Manna A, Saha S, Mohanty S,
Mukherjee S, Mazumdar M, Guha D and Das T: Aspirin inhibits
epithelial-to-mesenchymal transition and migration of oncogenic
K-ras-expressing non-small cell lung carcinoma cells by
down-regulating E-cadherin repressor slug. BMC Cancer. 16:392016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Petrera M, Paleari L, Clavarezza M,
Puntoni M, Caviglia S, Briata IM, Oppezzi M, Mislej EM, Stabuc B,
Gnant M, et al: The ASAMET trial: A randomized, phase II,
double-blind, placebo-controlled, multicenter, 2×2 factorial
biomarker study of tertiary prevention with low-dose aspirin and
metformin in stage I–III colorectal cancer patients. BMC Cancer.
18:12102018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muqbil I, Wu J, Aboukameel A, Mohammad RM
and Azmi AS: Snail nuclear transport: The gateways regulating
epithelial- to-mesenchymaltransition? Semin Cancer Biol. 27:39–45.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Roche J, Nasarre P, Gemmill R, Baldys A,
Pontis J, Korch C, Guilhot J, Ait-Si-Ali S and Drabkin H: Global
decrease of histone H3K27 acetylation in ZEB1-induced epithelial to
mesenchymal transition in lung cancer cells. Cancers (Basel).
5:334–356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou W, Ni TK, Wronski A, Glass B,
Skibinski A, Beck A and Kuperwasser C: The SIRT2 deacetylase
stabilizes Slug to control malignancy of basal-like breast cancer.
Cell Rep. 17:1302–1317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flossmann E and Rothwell PM; British
Doctors Aspirin Trial and the UK-TIA Aspirin Trial, : Effect of
aspirin on long-term risk of colorectal cancer: Consistent evidence
from randomised and observational studies. Lancet. 369:1603–1613.
2017. View Article : Google Scholar
|
|
32
|
Ni C and Yang L: Aspirin to inhibit the
formation and EMT of circulating tumor cells in patients with
metastatic colorectal cancer but not breast cancer. J Clinl Oncol.
35:e230242017. View Article : Google Scholar
|
|
33
|
Pozzoli G, Marei HE, Althani A, Boninsegna
A, Casalbore P, Marlier LN, Lanzilli G, Zonfrillo M, Petrucci G,
Rocca B, et al: Aspirin inhibits cancer stem cells properties and
growth of glioblastoma multiforme through Rb1 pathway modulation. J
Cell Physiol. Jan 30–2019.(Epub ahead of print). doi:
10.1002/jcp.28194. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hull MA, Sprange K, Hepburn T, Tan W,
Shafayat A, Rees CJ, Clifford G, Logan RF, Loadman PM, Williams EA,
et al: Eicosapentaenoic acid and aspirin, alone and in combination,
for the prevention of colorectal adenomas (seAFOod Polyp Prevention
trial): A multicentre, randomised, double-blind, placebo-
controlled, 2×2 factorial trial. Lancet. 392:2583–2594. 2018.
View Article : Google Scholar : PubMed/NCBI
|
